Decibel Cannabis acquires AgMedica, plans private placement

AgMedica's facility should help beef Decibel's export capabilities as it moves away from Canadian retail.

Canadian licensed producer Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) said Monday that it acquired AgMedica Bioscience Ltd. for a C$6.3 million unsecured convertible debenture.

The transaction adds AgMedica’s EU GMP and IMC-GAP certified annual flower production capacity of 5.1 metric tons per annum, bringing Decibel’s total exportable flower production to more than 12 metric tons annually when combined with its GACP facility, the news release noted.

Decibel CEO Benjamin Sze called the facility “the cornerstone of our international strategy” amid the Alberta-based firm’s latest leanings toward exports elsewhere across the Atlantic. The company sold off all of its Prairie Records retail stores earlier this year.

He added, “This marks the first step of Decibel’s new strategy as we execute on profitable growth opportunities enhanced by synergistic and accretive transactions.”

Decibel projects Ontario-based LP could contribute C$30 million of net revenue and C$4 million of EBITDA in 2025. On a pro-forma basis, Decibel anticipates total 2025 net revenue of C$130 million and adjusted EBITDA of C$25 million. The company said it paid an estimated 1.6x EBITDA multiple for AgMedica based on management’s 2025 projections.

Decibel also announced plans for a non-brokered private placement of common shares to raise between C$3 million to C$3.5 million, with terms to be determined and announced later.

The company gave a look-ahead at its third-quarter numbers next month as well, expecting net revenue between C$23 million to C$25 million and adjusted EBITDA of C$4 million to C$6 million. The guidance is based on its “new international exports within the quarter, sustained domestic sales, and new product launches.”

In August, Decibel posted a 22% year-over-year drop in net revenue to C$22.1 million, citing heightened competition in the infused pre-roll segment and a shift in vape consumer preferences.

Management said at the time that it paused capital spending and to focus on cost cuts ahead of new U.K. exports in the third quarter. Sze also noted positive “early indications” from relaunching the Qwest flower brand.

Avatar photo

Adam Jackson

Adam Jackson writes about the cannabis industry for the Green Market Report. He previously covered the Missouri Statehouse for the Columbia Missourian and has written for the Missouri Independent. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. You can find him on Twitter at @adam_sjackson and email him at adam.jackson@crain.com.


Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE